US EditionSAI Parenteral’s Ltd. Expands Global Reach with INR 125 Crore Acquisition of Australia’s Noumed Pharmaceuticals - Business News Week
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
SAI Parenteral’s Ltd. Expands Global Reach with INR 125 Crore Acquisition of Australia’s Noumed Pharmaceuticals - Business News Week
Hyderabad, Dec 01: SAI Parenteral’s Limited (SPL), a diversified pharmaceutical formulation company, today announced the acquisition of a 74.6% controlling stake in Noumed Pharmaceuticals Pty Ltd, an Adelaide-based pharmaceutical company, for an aggregate sum of INR 125 crore. SAI Parenterals has also filed its IPO DRHP with SEBI in September 30, 2025 – the offer, with […] The post SAI Parenteral’s Ltd. Expands Global Reach with INR 125 Crore Ac…
SAI Parenterals acquires 74.6% stake in Noumed Pharmaceuticals for INR 125 crore
SAI Parenteral’s Limited (SPL), a diversified pharmaceutical formulation company, announced the acquisition of a 74.6 per cent controlling stake in Noumed Pharmaceuticals, an Adelaide-based pharmaceutical company, for INR 125 crore. SAI Parenterals has filed its IPO Draft Red Herring Prospectus (DRHP) with SEBI on 30 September 2025. The offer, with a face value of Rs 5 per equity share, comprises a fresh issue of up to Rs 285 crore and an offer …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
